Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

Biosensor startup Biolinq said Thursday it has raised $4.75 million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 [?]